A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction

Annals of Oncology

Volumn 27, Issue 4, 2016, Pages 660-667

  Klevebro, F ^a   von Döbeln, G Alexandersson ^a   Wang, N ^a   Johnsen, G ^b   Jacobsen, A B ^c   Friesland, S ^a   Hatlevoll, I ^b   Glenjen, N I ^d   Lind, P ^e   Tsai, J A ^a   Lundell, L ^a   Nilsson, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chemoradiotherapy; Chemotherapy; Neoadjuvant treatment; Oesophageal carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANASTOMOSIS; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CAUSE OF DEATH; CHYLOTHORAX; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GASTROESOPHAGEAL CANCER; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HUMAN; INFECTION; KIDNEY FAILURE; LONG TERM SURVIVAL; LUNG EMBOLISM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NECROSIS; NEUTROPENIA; NORWAY; NUTRITIONAL DEFICIENCY; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECURRENT LARYNGEAL NERVE PALSY; RESPIRATORY FAILURE; SEPTICEMIA; STOMACH CANCER; SURVIVAL TIME; SWEDEN; THORACOTOMY; THROMBOCYTOPENIA; TREATMENT RESPONSE; ADENOCARCINOMA; CANCER STAGING; DISEASE FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL JUNCTION; MIDDLE AGED; NEOADJUVANT THERAPY; PATHOLOGY; REMISSION; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NORWAY; REMISSION INDUCTION; SWEDEN; TREATMENT OUTCOME;

EID: 84964677841     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdw010     Document Type: Article

References (19)

1. van Hagen P, Hulshof MC, van Lanschot JJ et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
2. Ychou M, Boige V, Pignon JP et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011; 29: 1715-1721.
3. Sjoquist KM, Burmeister BH, Smithers BM et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681-692.
4. Kranzfelder M, Schuster T, Geinitz H et al. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 2011; 98: 768-783.
5. Stahl M, Walz MK, Stuschke M et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009; 27: 851-856.
6. Burmeister BH, Thomas JM, Burmeister EA et al. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer 2011; 47: 354-360.
7. Davies AR, Gossage JA, Zylstra J et al. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol 2014; 32: 2983-2990.
8. Chirieac LR, Swisher SG, Ajani JA et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 2005; 103: 1347-1355.
9. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-1459.
10. Klevebro F, Johnsen G, Johnson E et al. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: a randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation. Eur J Surg Oncol 2015; 41: 920-926.
11. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007; 25: 4110-4117.
12. Allum WH, Stenning SP, Bancewicz J et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009; 27: 5062-5067.
13. Alderson D, Langley R, Nankivell MG et al. Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). J Clin Oncol 2015 ASCO Annual Meeting (29 May-2 June 2015). Vol. 33, No 15_suppl) (May 20 Supplement), 2015: 4002. © 2015 American Society of Clinical Oncology: 2015. http://hwmaint.meeting.ascopubs.org/cgi/content/abstract/33/ 15_suppl/4002 (16 February 2016, date last accessed).
14. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467.
15. Tepper J, Krasna MJ, Niedzwiecki D et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-1092.
16. Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
17. Kumagai K, Rouvelas I, Tsai JA et al. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg 2014; 101: 321-338.
18. Mariette C, Dahan L, Mornex F et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III Trial FFCD 9901. J Clin Oncol 2014; 32: 2416-2422.
19. Bosset JF, Gignoux M, Triboulet JP et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167.